Who's buying Veraxa Biotech AG - Post de-SPAC?

VRXA insider buying, 13F and 13D filings

• Oct 21, 2026Insider buy
  Christoph Samuel Ziegler (Director): Bought $33K on the open market
  30.0K shares at ~$1.09, traded 2026-10-20. Now holds 37.9K shares (stake up 378%).
  View the filing on SEC EDGAR ↗

Signals come from SEC filings: Form 4 (insiders, filed within 2 business days), 13F (fund holdings, up to 45 days after quarter end) and Schedule 13D (5%+ activist stakes). This page reports what the filings show; it is not investment advice.